Group psychotherapies for depression in persons with HIV: A systematic review
- PMID: 24459301
- PMCID: PMC3890933
- DOI: 10.4103/0019-5545.120541
Group psychotherapies for depression in persons with HIV: A systematic review
Abstract
Studies investigating effectiveness of group psychotherapy intervention in depression in persons with HIV have showed varying results with differing effect sizes. A systematic review of randomized controlled trials of group psychotherapy in depression in persons with HIV has been conducted to present the best available evidence in relation to its effect on depressive symptomatology. Electronic databases were searched to identify randomized controlled trials. Selected studies were quality assessed and data extracted by two reviewers. If feasible, it was planned to conduct a meta-analysis to obtain a pooled effect size of group psychotherapeutic interventions on depressive symptoms. Odds ratio for drop out from group was calculated. The studies were assessed for their quality using the Quality Rating Scale and other parameters for quality assessment set out by COCHRANE. The quality of reporting of the trials was compared against the Consolidated Standards of Reporting Trials (CONSORT) checklist for non-pharmacological studies (CONSORT-NPT). Four studies met the full inclusion criteria for systematic review. The trials included in the review examined group interventions based on the Cognitive behavioral therapy model against other therapeutic interventions or waiting list controls. In all four studies, group psychotherapy was an effective intervention for reducing depressive symptoms in persons with HIV in comparison to waiting list controls. The reported benefits from the group psychotherapy in comparison to active controls were less impressive. There were no statistically significant differences in drop outs at post treatments across group psychotherapy, wait list control, and other active interventions. The methodological quality of the studies varied. The quality of reporting of the studies was sub-optimal. The results of this systematic review support that group psychological interventions for depression in persons with HIV have a significant effect on depressive symptomatology. This review also indicates that group cognitive behavioral therapies are an acceptable psychological intervention for persons with HIV and comorbid depression.
Keywords: Depression; HIV; group psychotherapy.
Conflict of interest statement
Similar articles
-
Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.Health Technol Assess. 2020 Sep;24(43):1-312. doi: 10.3310/hta24430. Health Technol Assess. 2020. PMID: 32924926 Free PMC article.
-
Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.Health Technol Assess. 2020 Jun;24(28):1-232. doi: 10.3310/hta24280. Health Technol Assess. 2020. PMID: 32568666 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Psychosocial interventions for preventing and treating depression in dialysis patients.Cochrane Database Syst Rev. 2019 Dec 2;12(12):CD004542. doi: 10.1002/14651858.CD004542.pub3. Cochrane Database Syst Rev. 2019. PMID: 31789430 Free PMC article.
-
Nonsomatic treatment of depression.Child Adolesc Psychiatr Clin N Am. 2002 Jul;11(3):579-93. doi: 10.1016/s1056-4993(02)00009-3. Child Adolesc Psychiatr Clin N Am. 2002. PMID: 12222084 Review.
Cited by
-
Antidepressants for depression in adults with HIV infection.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD008525. doi: 10.1002/14651858.CD008525.pub3. Cochrane Database Syst Rev. 2018. PMID: 29355886 Free PMC article.
-
Exploring the barriers to the antiretroviral therapy adherence among people living with HIV in Bangladesh: A qualitative approach.PLoS One. 2022 Oct 21;17(10):e0276575. doi: 10.1371/journal.pone.0276575. eCollection 2022. PLoS One. 2022. PMID: 36269716 Free PMC article.
-
Depression in HIV infected patients: a review.Curr Psychiatry Rep. 2015 Jan;17(1):530. doi: 10.1007/s11920-014-0530-4. Curr Psychiatry Rep. 2015. PMID: 25413636 Review.
-
Major depressive disorder: Validated treatments and future challenges.World J Clin Cases. 2021 Nov 6;9(31):9350-9367. doi: 10.12998/wjcc.v9.i31.9350. World J Clin Cases. 2021. PMID: 34877271 Free PMC article. Review.
-
Health outcomes and cost-effectiveness of treating depression in people with HIV in Sub-Saharan Africa: a model-based analysis.AIDS Care. 2021 Apr;33(4):441-447. doi: 10.1080/09540121.2020.1719966. Epub 2020 Jan 27. AIDS Care. 2021. PMID: 31986900 Free PMC article.
References
-
- Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008;5:163–71. - PubMed
-
- Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70:539–45. - PubMed
-
- Tegger MK, Crane HM, Tapia KA, Uldall KK, Holte SE, Kitahata MM. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDs. 2008;22:233–43. - PubMed
-
- Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47:384–90. - PubMed
-
- Vranceanu AM, Safren SA, Lu M, Coady WM, Skolnik PR, Rogers WH, et al. The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV. AIDS Patient Care STDs. 2008;22:313–21. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous